Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,859 | N/A | -1,244,000 | 47,000 | -267,000 |
| Depreciation Amortization | 271 | N/A | 710,000 | 576,000 | 292,000 |
| Income taxes - deferred | N/A | N/A | -45,000 | -477,000 | -1,000 |
| Accounts receivable | N/A | N/A | 42,000 | -64,000 | 161,000 |
| Accounts payable and accrued liabilities | 1,689 | N/A | N/A | N/A | N/A |
| Other Working Capital | 1,405 | N/A | 360,000 | -56,000 | 35,000 |
| Other Operating Activity | -340 | 0 | 822,000 | 68,000 | -57,000 |
| Operating Cash Flow | $-11,834 | $N/A | $645,000 | $94,000 | $163,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,647 | N/A | -117,000 | -301,000 | -114,000 |
| Net Acquisitions | N/A | N/A | N/A | -6,078,000 | N/A |
| Other Investing Activity | 0 | 0 | 24,000 | 11,000 | -5,148,000 |
| Investing Cash Flow | $-1,647 | $N/A | $-93,000 | $-6,368,000 | $-5,262,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 3,014,000 | 66,000 | 5,055,000 |
| Debt Repayment | N/A | N/A | -589,000 | -31,000 | -14,000 |
| Common Stock Issued | N/A | N/A | 359,000 | -6,000 | 1,106,000 |
| Common Stock Repurchased | N/A | N/A | N/A | -250,000 | 0 |
| Dividend Paid | N/A | N/A | -22,000 | -23,000 | N/A |
| Other Financing Activity | 19,989 | 0 | -20,000 | -21,000 | -21,000 |
| Financing Cash Flow | $19,989 | $N/A | $2,742,000 | $-265,000 | $6,126,000 |
| Beginning Cash Position | 8,124 | N/A | 544,000 | 7,083,000 | 843,000 |
| End Cash Position | 14,632 | N/A | 3,838,000 | 544,000 | 1,870,000 |
| Net Cash Flow | $6,508 | $N/A | $3,294,000 | $-6,539,000 | $1,027,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,834 | N/A | 645,000 | 94,000 | 163,000 |
| Capital Expenditure | -1,647 | N/A | -293,000 | -301,000 | -132,000 |
| Free Cash Flow | -13,481 | 0 | 352,000 | -207,000 | 31,000 |